B-type natriuretic peptide reverses vascular endothelial insulin resistance and ameliorates dysregulated redox signalling when administered alongside insulin in human atherosclerosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease and chronic coronary syndromes Coronary Microcirculation and Collaterals ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by